These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35798874)

  • 21. Gene and prognostic value of N6-methyladenosine (m6A) modification regulatory factors in lung adenocarcinoma.
    Zhang D; Zhang D; Wang C; Yang X; Zhang R; Li Q; Xiong Y
    Eur J Cancer Prev; 2022 Jul; 31(4):354-362. PubMed ID: 34519693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8.
    Zhou L; Zhong Y; Wang F; Guo Y; Mao R; Xie H; Zhang Y; Li J
    Int J Biol Sci; 2024; 20(5):1763-1777. PubMed ID: 38481803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
    Zheng H; Cao Z; Lv Y; Cai X
    Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
    Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
    J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis.
    Hong L; Herjan T; Chen X; Zagore LL; Bulek K; Wang H; Yang CJ; Licatalosi DD; Li X; Li X
    J Exp Med; 2024 Jul; 221(7):. PubMed ID: 38861022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIF-1
    Lyu Y; Zhang Y; Wang Y; Luo Y; Ding H; Li P; Ni G
    J Immunol Res; 2022; 2022():6130806. PubMed ID: 35733918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.
    Fan Y; Li X; Sun H; Gao Z; Zhu Z; Yuan K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of N6-methyladenosine modification in pathogenesis of ischemic stroke.
    Chang H; Yang J; Wang Q; Zhao J; Zhu R
    Expert Rev Mol Diagn; 2022 Mar; 22(3):295-303. PubMed ID: 35236212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
    Wang J; Luo J; Wu X; Li Z
    Histol Histopathol; 2024 May; 39(5):633-646. PubMed ID: 37933909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
    Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
    Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
    Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
    Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
    [No Abstract]   [Full Text] [Related]  

  • 33. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
    Zhang X; Cai X
    Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR.
    Kong Z; Lu Y; Yang Y; Chang K; Lin Y; Huang Y; Wang C; Zhang L; Xu W; Zhao S; Li Y
    Mol Cancer Res; 2023 Dec; 21(12):1342-1355. PubMed ID: 37647111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WTAP promotes macrophage recruitment and increases VEGF secretion via N6-methyladenosine modification in corneal neovascularization.
    Bai Y; Jiao X; Hu J; Xue W; Zhou Z; Wang W
    Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166708. PubMed ID: 37019244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FTO-Dependent N
    Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
    Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WTAP promotes myocardial ischemia/reperfusion injury by increasing endoplasmic reticulum stress via regulating m
    Wang J; Zhang J; Ma Y; Zeng Y; Lu C; Yang F; Jiang N; Zhang X; Wang Y; Xu Y; Hou H; Jiang S; Zhuang S
    Aging (Albany NY); 2021 Mar; 13(8):11135-11149. PubMed ID: 33819187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased N6-methyladenosine causes infertility is associated with FTO expression.
    Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
    J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.